Skip to main navigation
Skip to search
Skip to main content
Region Zealand Home
Help & FAQ
Link opens in a new tab
Dansk
English
Search content at Region Zealand
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Courses
Press/Media
Impacts
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials
Giuseppe De Luca
*
, Maurits T. Dirksen
,
Henning Kelbæk
, Leif Thuesen
, Marteen A. Vink
, Christoph Kaiser
, Tania Chechi
, Gaia Spaziani
, Emilio Di Lorenzo
, Harry Suryapranata
, Gregg W. Stone
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Explore the research areas of 'Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials'.
Sort by
Weight
Alphabetically
Keyphrases
Randomized Trial
100%
Meta-analysis
100%
Bare Metal Stent
100%
Patient-level
100%
Paclitaxel-eluting Stent
100%
Paclitaxel
100%
Primary Percutaneous Coronary Intervention (pPCI)
100%
Stent Thrombosis
66%
ST-elevation Myocardial Infarction (STEMI)
66%
Reinfarction
50%
No Significant Difference
33%
Individual Patient Data
33%
Event Rate
16%
Cox Regression Analysis
16%
High Risk
16%
Kaplan-Meier
16%
Baseline Characteristics
16%
Survival Analysis
16%
Survival Curve
16%
Drug-eluting Stent
16%
Dual Antiplatelet Therapy
16%
Long-term Efficacy
16%
1-year Follow-up
16%
Myocardial Infarction Patients
16%
3-year Follow-up
16%
Long-term Safety
16%
Drug-eluting Stent Implantation
16%
Cumulative Mortality
16%
Estimated Probability
16%
Nursing and Health Professions
Bare Metal Stent
100%
Percutaneous Coronary Intervention
100%
Meta Analysis
100%
Paclitaxel
100%
Stent
85%
Stent Thrombosis
57%
ST Segment Elevation Myocardial Infarction
57%
Drug Eluting Stent
28%
Patient Coding
28%
Survival Analysis
14%
Proportional Hazards Model
14%
Dual Antiplatelet Therapy
14%
Event Free Survival
14%
Regression Analysis
14%
Accident Prevention
14%
Medicine and Dentistry
Meta-Analysis
100%
Primary Percutaneous Coronary Intervention
100%
Paclitaxel
100%
Stent Thrombosis
57%
ST Segment Elevation Myocardial Infarction
57%
Patient-Data
28%
Drug-Eluting Stent
28%
Proportional Hazards Model
14%
Survival Analysis
14%
Antiplatelet
14%
Event Free Survival
14%
Regression Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Stent Thrombosis
57%
ST Segment Elevation Myocardial Infarction
57%
Antiplatelet
14%
Event Free Survival
14%